Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMDNASDAQ:BLACNASDAQ:PSTVOTCMKTS:UAHC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.76-10.7%$2.90$1.75▼$8.44$3.54M1.89196,395 shs66,445 shsBLACBellevue Life Sciences Acquisition$1.41-13.5%$1.34$3.01▼$13.40$5.70M-0.0820,837 shs99,949 shsPSTVPlus Therapeutics$0.31-10.3%$0.54$0.24▼$2.31$5.34M0.645.37 million shs1.96 million shsUAHCUnited American Healthcare$0.01+0.7%$0.01$0.01▼$0.11$1.63M-1.5421,344 shs200 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%-33.31%-45.00%-41.11%-57.90%BLACBellevue Life Sciences Acquisition-13.50%+3.68%+16.53%-1.74%-86.88%PSTVPlus Therapeutics0.00%-3.53%-38.02%-53.74%-85.66%UAHCUnited American Healthcare0.00%0.00%-4.79%-36.82%-46.50%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical3.0896 of 5 stars3.55.00.00.02.50.01.3BLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/AN/AN/APSTVPlus Therapeutics2.3785 of 5 stars3.34.00.00.03.00.00.6UAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 3.00Buy$56.003,081.82% UpsideBLACBellevue Life Sciences Acquisition 0.00N/AN/AN/APSTVPlus Therapeutics 2.50Moderate Buy$11.673,615.50% UpsideUAHCUnited American Healthcare 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest UAHC, PSTV, BLAC, and AEMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/5/2025PSTVPlus TherapeuticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$20.00 ➝ $20.505/5/2025PSTVPlus TherapeuticsD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/5/2025PSTVPlus TherapeuticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold4/21/2025PSTVPlus TherapeuticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$19.00 ➝ $20.003/28/2025PSTVPlus TherapeuticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.003/28/2025PSTVPlus TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $5.503/17/2025PSTVPlus TherapeuticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$9.00 ➝ $9.00(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K6.21N/AN/A$2.19 per share0.80BLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/APSTVPlus Therapeutics$4.91M1.09N/AN/A($0.30) per share-1.05UAHCUnited American HealthcareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$12.21M-$12.64N/AN/AN/AN/A-153.96%-109.13%6/26/2025 (Estimated)BLACBellevue Life Sciences AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/APSTVPlus Therapeutics-$13.32M-$2.94N/AN/AN/A-225.07%N/A-154.56%8/13/2025 (Estimated)UAHCUnited American Healthcare$720KN/A0.00∞N/AN/AN/AN/AN/ALatest UAHC, PSTV, BLAC, and AEMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/26/2025Q4 2025AEMDAethlon Medical-$0.13N/AN/AN/AN/AN/A5/30/2025Q1 2025PSTVPlus Therapeutics-$0.17-$0.56-$0.39-$1.19$1.11 million$1.06 million3/27/2025Q4 2024PSTVPlus Therapeutics-$0.51-$0.67-$0.16-$0.67$1.19 million$1.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/ABLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/APSTVPlus TherapeuticsN/AN/AN/AN/AN/AUAHCUnited American Healthcare$0.08575.54%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A2.802.80BLACBellevue Life Sciences AcquisitionN/AN/AN/APSTVPlus TherapeuticsN/A0.440.44UAHCUnited American HealthcareN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%BLACBellevue Life Sciences Acquisition55.30%PSTVPlus Therapeutics3.28%UAHCUnited American HealthcareN/AInsider OwnershipCompanyInsider OwnershipAEMDAethlon Medical1.20%BLACBellevue Life Sciences Acquisition33.67%PSTVPlus Therapeutics3.76%UAHCUnited American Healthcare14.31%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.01 million14.30 millionNo DataBLACBellevue Life Sciences AcquisitionN/A4.04 million2.68 millionNot OptionablePSTVPlus Therapeutics2017.00 million5.57 millionNot OptionableUAHCUnited American Healthcare31117.06 million100.31 millionNot OptionableUAHC, PSTV, BLAC, and AEMD HeadlinesRecent News About These CompaniesUnited American Healthcare CorpShsMay 6, 2025 | markets.businessinsider.comUnited Healthcare data breach may have affected 190 million AmericansJanuary 27, 2025 | msn.comUnitedHealth CEO: American healthcare needs to be "less complex and less confusing'January 17, 2025 | msn.comUnitedHealth tops profit forecasts but medical costs linger for health care giantJanuary 16, 2025 | msn.comNews Wrap: United Healthcare CEO killed in brazen and targeted attack, New York police sayDecember 5, 2024 | pbs.orgHH Health System, United Healthcare reach agreementNovember 14, 2024 | elkvalleytimes.comUnited Healthcare reaches deal with Huntsville Hospital Health SystemNovember 14, 2024 | decaturdaily.comHow will a Trump presidency reshape US public health? A look at his plans.November 13, 2024 | usatoday.comDreamers eligible for health insurance through Covered California for first time this yearNovember 8, 2024 | thecalifornian.comDuke Health, UnitedHealthcare reach multi-year agreement, impacts over 172K patientsNovember 3, 2024 | msn.comAs ACA sign ups start, more Americans have health insurance than ever. Will it last?November 2, 2024 | msn.comUSA Health sets gala to celebrate health care workers’ impact on patientsOctober 31, 2024 | msn.comUnitedHealth Confirms Change Healthcare Data Breach Impacted 100 Million AmericansOctober 29, 2024 | cpomagazine.comMore than 100 million Americans had their health data exposed in a UnitedHealth hackOctober 26, 2024 | 9to5mac.comCyberattack at UnitedHealth subsidiary Change Healthcare affected 100M AmericansOctober 24, 2024 | startribune.comMore than 1,500 physicians call on Trump to release health care planOctober 18, 2024 | msn.comNew center aims to enhance public health preparedness in Utah and beyondOctober 11, 2024 | msn.comThe Plastic-Free Movement: Redefining Healthcare Disinfection for a Healthier PlanetOctober 9, 2024 | beckershospitalreview.comHealth Care Is on the Ballot AgainOctober 4, 2024 | theatlantic.comNew United Against the Flu toolkit urges vaccination before peak respiratory virus seasonSeptember 28, 2024 | aha.orgNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsSuper Micro Computer Stock Finding Upside With NVIDIA's BlackwellBy Gabriel Osorio-Mazilli | May 30, 2025View Super Micro Computer Stock Finding Upside With NVIDIA's BlackwellUAHC, PSTV, BLAC, and AEMD Company DescriptionsAethlon Medical NASDAQ:AEMD$1.76 -0.21 (-10.66%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.80 +0.03 (+1.99%) As of 06/13/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Bellevue Life Sciences Acquisition NASDAQ:BLAC$1.41 -0.22 (-13.50%) As of 06/13/2025Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.Plus Therapeutics NASDAQ:PSTV$0.31 -0.04 (-10.29%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$0.32 +0.00 (+0.32%) As of 06/13/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.United American Healthcare OTCMKTS:UAHC$0.01 +0.00 (+0.72%) As of 06/13/2025 09:30 AM EasternUnited American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
